Literature DB >> 16982619

Bmi-1 regulates the differentiation and clonogenic self-renewal of I-type neuroblastoma cells in a concentration-dependent manner.

Hongjuan Cui1, Jun Ma, Jane Ding, Tai Li, Goleeta Alam, Han-Fei Ding.   

Abstract

Human neuroblastoma I-type cells have been proposed as a population of malignant neural crest stem cells, based on their high tumorigenic potential, expression of stem cell markers, and ability to differentiate into cells of neural crest lineages, including neuroblastic (N-type) and Schwann/glial (S-type) cells. Here, we demonstrate at single cell levels that a subpopulation of I-type cells possess clonogenic self-renewal capacity that requires the Polycomb group family transcription repressor Bmi-1. We further show that Bmi-1 expression levels exert an instructive influence on lineage commitment by I-type cells. Spontaneous and induced differentiation of I-type cells into S-type cells is accompanied by a marked reduction in the level of Bmi-1 expression, and enforced down-regulation of BMI-1 facilitates spontaneous differentiation of I-type cells into S-type cells. By contrast, N-type neuroblastoma cell lines and differentiated N-type cells express higher levels of Bmi-1 relative to I-type cells, and overexpression of BMI-1 promotes the differentiation of I-type cells along the neuronal lineage. Thus, Bmi-1 acts in a concentration-dependent manner in the control of the delicate balance between the self-renewal and differentiation of neuroblastoma I-type cells. These observations suggest that graded activation of a master regulator within individual tumors could trigger divergent developmental programs responsible for both tumor growth and heterogeneity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16982619     DOI: 10.1074/jbc.M604009200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

Review 1.  Wilms tumor--a renal stem cell malignancy?

Authors:  Naomi Pode-Shakked; Benjamin Dekel
Journal:  Pediatr Nephrol       Date:  2011-04-16       Impact factor: 3.714

2.  Impaired odontogenic differentiation of senescent dental mesenchymal stem cells is associated with loss of Bmi-1 expression.

Authors:  Shebli Mehrazarin; Ju Eun Oh; Christine L Chung; Wei Chen; Reuben H Kim; Songtao Shi; No-Hee Park; Mo K Kang
Journal:  J Endod       Date:  2011-05       Impact factor: 4.171

3.  REST interacts with Cbx proteins and regulates polycomb repressive complex 1 occupancy at RE1 elements.

Authors:  Xiaojun Ren; Tom K Kerppola
Journal:  Mol Cell Biol       Date:  2011-03-14       Impact factor: 4.272

4.  Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma.

Authors:  Veronica Veschi; Zhihui Liu; Ty C Voss; Laurent Ozbun; Berkley Gryder; Chunhua Yan; Ying Hu; Anqi Ma; Jian Jin; Sharlyn J Mazur; Norris Lam; Barbara K Souza; Giuseppe Giannini; Gordon L Hager; Cheryl H Arrowsmith; Javed Khan; Ettore Appella; Carol J Thiele
Journal:  Cancer Cell       Date:  2017-01-09       Impact factor: 31.743

Review 5.  Genetics and Epigenetics in Adult Neurogenesis.

Authors:  Jenny Hsieh; Xinyu Zhao
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-06-01       Impact factor: 10.005

6.  MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas.

Authors:  Ruimin Huang; Nai-Kong V Cheung; Jelena Vider; Irene Y Cheung; William L Gerald; Satish K Tickoo; Eric C Holland; Ronald G Blasberg
Journal:  FASEB J       Date:  2011-08-19       Impact factor: 5.191

7.  Calreticulin regulates MYCN expression to control neuronal differentiation and stemness of neuroblastoma.

Authors:  Andy Chi-Lung Lee; Yu-Yin Shih; Fanfan Zhou; Tsi-Chian Chao; Hsinyu Lee; Yung-Feng Liao; Wen-Ming Hsu; Ji-Hong Hong
Journal:  J Mol Med (Berl)       Date:  2019-01-05       Impact factor: 4.599

8.  Bmi-1-shRNA inhibits the proliferation of lung adenocarcinoma cells by blocking the G1/S phase through decreasing cyclin D1 and increasing p21/p27 levels.

Authors:  Xiangyu Zheng; Yifang Wang; Ben Liu; Chunqing Liu; Dandan Liu; Jie Zhu; Chunhui Yang; Jiangzhou Yan; Xiaobo Liao; Xiuxiang Meng; Hong Yang
Journal:  Nucleic Acid Ther       Date:  2014-02-19       Impact factor: 5.486

9.  Repression of Ca2+/calmodulin-dependent protein kinase IV signaling accelerates retinoic acid-induced differentiation of human neuroblastoma cells.

Authors:  David M Feliciano; Arthur M Edelman
Journal:  J Biol Chem       Date:  2009-07-24       Impact factor: 5.157

10.  Bmi-1 is essential for the tumorigenicity of neuroblastoma cells.

Authors:  Hongjuan Cui; Bo Hu; Tai Li; Jun Ma; Goleeta Alam; William T Gunning; Han-Fei Ding
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.